AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,332,503 | -6.9% | 315,759 | -31.6% | 0.00% | 0.0% |
| Q2 2023 | $1,431,537 | +438.7% | 461,786 | +141.5% | 0.00% | +300.0% |
| Q1 2023 | $265,758 | -76.9% | 191,193 | -66.9% | 0.00% | -75.0% |
| Q4 2022 | $1,150,578 | +132.4% | 578,180 | +387.1% | 0.00% | +300.0% |
| Q1 2022 | $495,000 | -62.4% | 118,698 | -56.8% | 0.00% | -66.7% |
| Q4 2021 | $1,316,000 | -37.2% | 274,719 | -30.0% | 0.00% | -40.0% |
| Q3 2021 | $2,097,000 | +296.4% | 392,612 | +279.7% | 0.01% | +400.0% |
| Q2 2021 | $529,000 | -89.4% | 103,393 | -86.0% | 0.00% | -92.3% |
| Q1 2021 | $4,979,000 | +94.9% | 739,768 | +39.6% | 0.01% | +62.5% |
| Q4 2019 | $2,555,000 | -1.5% | 530,067 | -40.8% | 0.01% | -11.1% |
| Q3 2019 | $2,595,000 | +151.5% | 894,869 | +521.7% | 0.01% | +200.0% |
| Q2 2019 | $1,032,000 | – | 143,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |